SCHEMBL7177347

SCHEMBL7177347

CCCCOc1ccc(C=CC(=O)c2ccc(C(=O)N(C)C)cc2)c(OCCCC)c1

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 2/20 0.57
CYP1B1 Q16678 2/20 0.57
DPP4 P27487 3/20 0.53
PTPN1 P18031 1/20 0.53
TNFRSF1A P19438 1/20 0.51
ABCG2 Q9UNQ0 1/20 0.51
BCHE P06276 4/20 0.48
ACHE P22303 2/20 0.47
KEAP1 Q14145 1/20 0.47
NFE2L2 Q16236 1/20 0.47
MAPT P10636 2/20 0.47
LMNA P02545 1/20 0.47
HPGD P15428 1/20 0.47
HDAC8 Q9BY41 2/20 0.47
NPC1 O15118 1/20 0.46
ALDH1A1 P00352 1/20 0.46
RAB9A P51151 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7185724 0.95 CYP1A1 (0.62) CYP1A1CYP1B1DPP4PTPN1TNFRSF1A
SCHEMBL7184981 0.88 CYP1A1 (0.61) CYP1A1CYP1B1DPP4TNFRSF1AABCG2
SCHEMBL7184986 0.88 CYP1A1 (0.61) CYP1A1CYP1B1DPP4TNFRSF1AABCG2
SCHEMBL9111707 0.88 CYP1A1 (0.67) CYP1A1CYP1B1DPP4PTPN1TNFRSF1A
SCHEMBL9112387 0.87 CYP1A1 (0.62) CYP1A1CYP1B1DPP4PTPN1TNFRSF1A
SCHEMBL9203813 0.87 LMNA (0.59) ABCG2BCHEACHEKEAP1NFE2L2
SCHEMBL7188854 0.87 ABCG2 (0.67) CYP1A1CYP1B1DPP4PTPN1TNFRSF1A
SCHEMBL9113143 0.87 TNFRSF1A (0.68) CYP1A1CYP1B1DPP4PTPN1TNFRSF1A
SCHEMBL7178752 0.86 CYP1A1 (0.59) CYP1A1CYP1B1DPP4PTPN1TNFRSF1A
SCHEMBL9113779 0.86 CYP1A1 (0.70) CYP1A1CYP1B1DPP4PTPN1TNFRSF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed